Issue 46: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.

Capable talent is increasingly difficult to find. Finding, nurturing and celebrating individuals is key to creating a strong, empowered workforce. Discover first-hand insights in our new report here: https://lnkd.in/e_dUWjiZ

Find out who’s made this year’s list of ‘𝙁𝙪𝙩𝙪𝙧𝙚 𝙇𝙚𝙖𝙙𝙚𝙧𝙨 𝙞𝙣 𝙋𝙝𝙖𝙧𝙢𝙖 𝙖𝙣𝙙 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚', all of whom were nominated by their peers for demonstrating exceptional influence, leadership and professional track record. Read first-hand insights and recommendations so you can encourage and foster the next generation of talent - next year’s Future Leaders could be within your company today: https://lnkd.in/e_dUWjiZ Congratulations to all of our listed nominees this year!

#pharmafutureleaders #pharmatalent #pharmaworkforce

IME is transforming professional development and patient care in the pharmaceutical industry. A recent Reuters webinar with industry leaders from Viiv Healthcare, Wiley, Astellas Pharma, and Daiichi Sankyo highlighted key strategies for optimizing IME's impact.

Key takeaways:

🔹 Balancing Independence & Strategy: Initiating IME in a product’s pre-licensing phase ensures unbiased education.

🔹 Tailoring Education: The importance of customizing content for diverse global audiences, particularly in HIV care.

🔹 Embracing Technology: AI and format diversity are crucial for delivering relevant, actionable insights.

🔹 Localization & Engagement: The need for regional adaptation and generational engagement to enhance learning experiences.

🔹 Transparency & Collaboration: Ensuring objectivity and building trust through transparent partnerships is vital for effective IME.

As we move forward, embracing these insights will enhance IME's role in advancing healthcare education and improving patient outcomes. Read now!

#Pharma #MedicalEducation #Innovation #HealthcareTransformation

Hear insights from Maya Martinez-Davis, President, US, GSK, on fostering collaboration and innovation in pharma. Discover strategies for trust-building, strategic partnerships, and leveraging data effectively. 🎧Listen to the latest PharmaPulse podcast episode here: https://bit.ly/4hJiZea or subscribe on Spotify for more industry-leading discussions: https://bit.ly/4dRxcmX #PharmaPulse #PharmaceuticalIndustry #pharmacollaboration #GSK

Top 5 pharma news to watch

1. Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea (Reuters.com, December 20)
2. A 'pivotal moment': Ionis enters next phase of commercial evolution with Tryngolza's FDA approval (Fierce Pharma, December 20)
3. GSK's cancer drug combo meets main goal in ovarian cancer trial (Reuters.com, December 20)
4. Novo’s next-gen obesity drug misses expectations in closely watched trial (Biopharma Dive, December 20)
5. Pfizer's Braftovi scores accelerated approval in colorectal cancer (FirstWord Pharma, December 20)

Event spotlight

📣 Are you ready to double down on human-led, tech-enabled, and data-driven strategies?

Reuters Events: Pharma USA 2025 (March 18-19, Philadelphia) is calling all pharma leaders! Join the most important meeting of 2025 for commercial, marketing, medical affairs, patient engagement, RWE, and market access professionals.

Don't just read about it - be in the room:

1200 attendees

170 Speakers

100% Top 50 Pharma

32 in depth case studies

20+ interactive sessions

Find out more!

#REpharmaUSA #PharmaFuture #HealthcareInnovation

Thanks for reading! If you have any feedback or would like to see something included in our newsletter, get in touch with our team!

EU Team

Daisy Beale

Ziyanda Dludla

Suzy Wang

Emma Haslam

USA Team

Charlotte Bastiaanse

Noah Dixon

Jacob Byerley

Samuel Baddeley

See you next time!